TY - JOUR
T1 - Predicting quality of life in veterans with heart failure
T2 - The role of disease severity, depression, and comorbid anxiety
AU - Cully, Jeffrey
AU - Phillips, Laura
AU - Kunik, Mark
AU - Stanley, Melinda
AU - Deswal, Anita
N1 - Funding Information:
This study was supported by Grant No. CDA-2 05-288, Career Development Award, from the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Service, Washington, DC, to Jeffrey Cully; Grant No. 07-105 Pilot Study Award, South Central Mental Illness Research Education and Clinical Center to Jeffrey Cully; and the Houston Center for Quality of Care & Utilization Studies (HFP90-020), HSR&D Service, Office of Research and Development. No funding agencies played a role in the design and conduct of this study or the analysis and interpretation of data.
PY - 2010/5/1
Y1 - 2010/5/1
N2 - This study focused on the relative contribution of heart failure (HF) disease severity, depression, and comorbid anxiety to quality of life for 96 ambulatory HF veterans (48 with and 48 without depressive symptoms). Primary analyses sought to predict HF quality of life using constructs including depression symptoms, comorbid anxiety symptoms, HF severity, medical-illness burden, and demographic factors. Multiple regression procedures found 3 significant predictors of better quality of life, including HF severity (β = -13.33, p < .001), depressive symptoms (β = -2.34, p = .003), and age (β = 0.76, p < .01). These results suggest that disease severity and depression, but not necessarily comorbid anxiety, significantly affect quality of life for HF patients. As HF is a progressive, deteriorating condition, mental health interventions, especially those that target depression, might offer opportunities for improved quality of life for HF patients.
AB - This study focused on the relative contribution of heart failure (HF) disease severity, depression, and comorbid anxiety to quality of life for 96 ambulatory HF veterans (48 with and 48 without depressive symptoms). Primary analyses sought to predict HF quality of life using constructs including depression symptoms, comorbid anxiety symptoms, HF severity, medical-illness burden, and demographic factors. Multiple regression procedures found 3 significant predictors of better quality of life, including HF severity (β = -13.33, p < .001), depressive symptoms (β = -2.34, p = .003), and age (β = 0.76, p < .01). These results suggest that disease severity and depression, but not necessarily comorbid anxiety, significantly affect quality of life for HF patients. As HF is a progressive, deteriorating condition, mental health interventions, especially those that target depression, might offer opportunities for improved quality of life for HF patients.
KW - Anxiety
KW - Cardiovascular disease
KW - Depression
KW - Mental health services
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=77952976819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952976819&partnerID=8YFLogxK
U2 - 10.1080/08964280903521297
DO - 10.1080/08964280903521297
M3 - Article
C2 - 20497945
AN - SCOPUS:77952976819
SN - 0896-4289
VL - 36
SP - 70
EP - 76
JO - Behavioral Medicine
JF - Behavioral Medicine
IS - 2
ER -